Fact CheckerSign in

NCT06758856Completed

Effect of Betaine and Choline on Metabolic Health

ABC (Additional Betaine and Choline) Study: Effect of Betaine and Choline Intake on Biomarkers of Metabolic Health in Humans

Source: ClinicalTrials.gov · Last updated 12 May 2026

Brief summary (registry, in English)

The purpose of this research is to determine whether extra betaine and choline influence metabolic health in adults with overweight and obesity.

Status (registry)
Completed
Study type
Interventional
Enrollment
34 (actual)
First submitted
18 Dec 2024
Start date
31 Jan 2025
Primary completion date
19 Aug 2025
Lead sponsor
University of Guelph
Diseases
Obesity
NCT number
NCT06758856

What you commit to

  • Study type: Interventional
  • Participants enrolled: 34
  • From 31 Jan 2025 to the primary completion date, 19 Aug 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Use of hormone therapy including birth control pills
  • Use of recreational drugs (may affect metabolic pathway for choline)

Other illness

  • Presence of chronic illnesses, e.g., heart disease, diabetes, cancer, celiac disease, inflammatory bowel disease (Crohn's disease and ulcerative colitis), gastrointestinal liver or kidney diseases or alcoholism
  • Diagnosis of trimethylaminuria (genetic disorder affecting choline use in body)
  • Have allergies to eggs or any anaphylactic food allergies

Age

  • Male or female \< 18 years or \> 70 years of age at the time of consent

Other

  • BMI \< 25 kg/m2; or BMI \> 35 kg/m2
  • Pregnant or planning to become pregnant during the course of the study; currently breastfeeding or postpartum \< 6 months
  • Follows a vegan diet
  • Current smoker (any form of nicotine, e-cigarettes, etc)
  • Use of antibiotics in the last 2 months
  • Use of prebiotics, probiotics or dietary fiber (i.e., Metamucil) supplements in the last 2 months
  • Have a schedule or lifestyle patterns incompatible with the study protocol

Who the study is looking for

  • Male or female participant of any race or ethnicity between 18-70 years of age (inclusive) at the time of informed consent
  • BMI between 25-35 kg/m2
  • Non-smoker
  • Willing to consume 3 eggs per day for one dietary period of 4 weeks
  • Willing to avoid eggs during the rest of the study including washout period breaks except for eggs that are provided
  • Willing to fast before the baseline and dietary period lab visits
  • Willing to provide a 24-hr prior day food record at the dietary period lab visits
  • Willing to provide or collect biological specimen samples at the baseline and dietary period lab visits
  • Willing to follow the study protocol including maintaining usual lifestyle during the entire study

Age in the registry: 18 years to 70 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Human Nutraceutical Research Unit
Coordinator of this site? Confirm its status
GuelphCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.